Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens

Urology

Volumn 83, Issue 2, 2014, Pages 511.e1-511.e7

  Väänänen, Riina Minna ^a   Lilja, Hans ^b,c,d,e   Kauko, Leni ^a   Helo, Pauliina ^a   Kekki, Henna ^a   Cronin, Angel M ^f   Vickers, Andrew J ^b   Nurmi, Martti ^g   Alanen, Kalle ^g   Bjartell, Anders ^e   Pettersson, Kim ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e LUND UNIVERSITY   (Sweden)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; BLADDER CANCER; CYSTECTOMY; FUSION GENE; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PCA3 GENE; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINK1 GENE; TMPRSS2 ERG FUSION GENE;

EID: 84893164596     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.11.005     Document Type: Article

References (29)

1. S.A. Tomlins, D.R. Rhodes, and S. Perner et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648
2. F. Demichelis, K. Fall, and S. Perner et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort Oncogene 26 2007 4596 4599
3. O.R. Saramäki, A.E. Harjula, and P.M. Martikainen et al. TMPRSS2: ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis Clin Cancer Res 14 2008 3395 3400
4. J. Clark, S. Merson, and S. Jhavar et al. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate Oncogene 26 2007 2667 2673
5. B. Furusato, C.L. Gao, and L. Ravindranath et al. Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer Mod Pathol 21 2008 67 75
6. S.K. Watson, B.W. Woolcock, and J.N. Fee et al. Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization Prostate 69 2009 961 975
7. J.H. Luo Gene expression alterations in human prostate cancer Drugs Today (Barc) 38 2002 713 719
8. Y.P. Yu, D. Landsittel, and L. Jing et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy J Clin Oncol 22 2004 2790 2799
9. F. Kosari, J.C. Cheville, and C.M. Ida et al. Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer Am J Pathol 181 2012 34 42
10. A. Paju, K. Hotakainen, and Y. Cao et al. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells Eur Urol 52 2007 1670 1679
11. S.A. Tomlins, D.R. Rhodes, and J. Yu et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers Cancer Cell 13 2008 519 528
12. S. Jhavar, D. Brewer, and S. Edwards et al. Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer BJU Int 103 2009 1256 1269
13. K.A. Leinonen, T.T. Tolonen, and H. Bracken et al. Association of SPINK1 expression and TMPRSS2: ERG fusion with prognosis in endocrine-treated prostate cancer Clin Cancer Res 16 2010 2845 2851
14. S.A. Tomlins, A. Bjartell, and A.M. Chinnaiyan et al. ETS gene fusions in prostate cancer: from discovery to daily clinical practice Eur Urol 56 2009 275 286
15. J. Wang, Y. Cai, and C. Ren et al. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer Cancer Res 66 2006 8347 8351
16. J. Nurmi, T. Wikman, and M. Karp et al. High-performance real-time quantitative RT-PCR using lanthanide probes and a dual-temperature hybridization assay Anal Chem 74 2002 3525 3532
17. R.M. Väänänen, H. Lilja, and A. Cronin et al. Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens Clin Biochem 46 2013 670 674
18. R.M. Väänänen, M. Rissanen, and O. Kauko et al. Quantitative real-time RT-PCR assay for PCA3 Clin Biochem 41 2008 103 108
19. J. Nurmi, H. Lilja, and A. Ylikoski Time-resolved fluorometry in end-point and real-time PCR quantification of nucleic acids Luminescence 15 2000 381 388
20. M. Rissanen, P. Helo, and R.M. Väänänen et al. Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood Clin Biochem 40 2007 111 118
21. J. Nurmi, A. Ylikoski, and T. Soukka et al. A new label technology for the detection of specific polymerase chain reaction products in a closed tube Nucleic Acids Res 28 2000 E28
22. L. Nonn, V. Ananthanarayanan, and P.H. Gann Evidence for field cancerization of the prostate Prostate 69 2009 1470 1479
23. D.P. Slaughter, H.W. Southwick, and W. Smejkal Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 1953 963 968
24. R. Mazzucchelli, F. Barbisan, and A. Santinelli et al. Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis Hum Pathol 42 2011 1931 1936
25. I. Popa, Y. Fradet, and G. Beaudry et al. Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization Mod Pathol 20 2007 1121 1127
26. M.J. Bussemakers, A. van Bokhoven, and G.W. Verhaegh et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer Cancer Res 59 1999 5975 5979
27. D. Hessels, J.M. Klein Gunnewiek, and I. van Oort et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer Eur Urol 44 2003 8 15
28. B. Laxman, D.S. Morris, and J. Yu et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer Cancer Res 68 2008 645 649
29. Y. Fukabori, K. Yoshida, and K. Nakano et al. Preparation of a single prostate needle biopsy specimen for histological diagnosis and RNA analysis J Urol 176 2006 1204 1207